CLS Americas Presents its TRANBERG™ System for Image-Guided Focal Laser Ablation at Focal Therapy Society 2023 Conference
07 sept. 2023 08h49 HE
|
Clinical Laserthermia Systems Americas, Inc.
WASHINGTON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- CLS Americas, a leading provider of office-based, focal laser ablation systems in the US urology market, today announced it will exhibit its TRANBERG™...
CLS Exhibits MRI-Guided, Focal Laser Ablation System for Prostate Cancer at the 94th National Congress of the Italian Society of Urology
15 oct. 2021 04h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
RICCIONE, Italy, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® Laser Thermal Therapy...
CLS Strengthens its Organization with New Employees in Key Positions for Continued Global Establishment
13 janv. 2021 03h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), a developer of advanced innovative products for high-precision, image-guided laser ablation, today...
CLS and Toronto General Hospital Continue Clinical Trial Collaboration Regarding MRI-Guided Laser Ablation Treatment of Prostate Cancer
17 nov. 2020 05h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the clinical study performed in collaboration with Toronto General Hospital, Canada,...
CLS Receives New CPT® Reimbursement Code Approval by American Medical Association for Ultrasound-Guided Focal Laser Ablation of Prostate Cancer
04 nov. 2020 02h30 HE
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the American Medical Association (AMA) has approved its application and issued a...
CLS and University Hospital Magdeburg launch clinical trial regarding focal laser ablation treatment of localized prostate cancer
12 oct. 2020 02h30 HE
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems (publ) and Otto-von-Guericke-University Magdeburg, Medical faculty are entering into an agreement regarding an...
CLS and Advanced Medical Systems Form Joint Venture Cooperation, Introducing the Innovative TRANBERG® Thermal Therapy System and imILT® in the Asia-Pacific Region
24 août 2020 03h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of innovative image-guided laser ablation technology for minimally invasive soft tissue and...
CLS Conducts In-Vivo Laser Ablation Studies for Neuro and Prostate using TRANBERG Thermal Therapy System with Thermoguide
22 mai 2020 04h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and LUND, Sweden, May 22, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it is conducting new in-vivo precision laser ablation treatment...
CLS Granted New U.S. Patent Covering Unique, Non-Cooled, Diffuser-type Laser Ablation Applicator
29 avr. 2020 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and LUND, Sweden, April 29, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it was granted a new U.S. Patent valid until 2036 covering its...